$FORTIS Fortis Healthcare reported strong Q4 FY26 results

Fortis Healthcare reported strong Q4 FY26 results with consolidated revenue rising 17.8% to ₹2,365 crore and net profit jumping 44.2% to ₹271 crore. The hospital business drove growth, contributing 85% of revenues, while diagnostics also showed double-digit gains. 📊 Fortis Healthcare Q4 FY26 Highlights Revenue: ₹2,365 crore (vs ₹2,007 crore in Q4 FY25, up 17.8%) Operating EBITDA: ₹531 crore (up 22.2%), margin at 22.5% (vs 21.7%) Net Profit (PAT): ₹271 crore (vs ₹188 crore, up 44.2%) Dividend: ₹1 per share (10% of face value) recommended by the board 🏥 Segment Performance Hospital Business Revenue: ₹2,023 crore (up 19% YoY) Annual Revenue: ₹7,773 crore (up 19.1%) Operating EBITDA: ₹446 crore in Q4 (margin 22.1%) Drivers: 15% increase in occupied beds (FY26) 17% increase in Q4 occupancy Growth in high-end procedures: Robotic surgeries +66% YoY, Radiation therapy +19% YoY Top 6 specialties (Cardiac, Orthopedics, Neurology, Gastroenterology, Oncology, Renal Sciences) grew 18.9% YoY, contributing 62% of hospital revenue Diagnostics Business (Agilus) Revenue: ₹387 crore in Q4 (up 11.1%) Annual Revenue: ₹1,527 crore (up 8.5%) Operating EBITDA: ₹85 crore in Q4 (margin 22%) Annual EBITDA: ₹360 crore (margin 23.6%, up from 17.7%) Test Volumes: 40.8 million (vs 39.2 million last year) Preventive portfolio revenue share rose to 13% (from 11%) 📈 Full-Year FY26 Performance Revenue: ₹9,128 crore (up 17.3% YoY) Operating EBITDA: ₹2,085 crore (up 31.3%), margin 22.8% (vs 20.4%) Net Profit (PAT): ₹1,064 crore (up 31.5%) International Patient Revenue: ₹639 crore (up 18.5%), contributing 7.8% of hospital revenue 📌 Key Takeaway Fortis Healthcare’s Q4 FY26 results show robust growth in hospital and diagnostics segments, driven by higher occupancy, specialty-led volumes, and expansion into advanced medical procedures. The company remains on a strong growth trajectory, though rising debt from acquisitions is a factor to monitor.